Presentation is loading. Please wait.

Presentation is loading. Please wait.

Industry Clinical Studies Contracted in 2013 and 2014 Services : 2013 No.Therapeutic areaStudy Phase Development Phase Services 1Chronic parasitic diseaseon.

Published byBrennan Critchett Modified over 9 years ago

Similar presentations

Presentation on theme: "Industry Clinical Studies Contracted in 2013 and 2014 Services : 2013 No.Therapeutic areaStudy Phase Development Phase Services 1Chronic parasitic diseaseon."— Presentation transcript:

1 Industry Clinical Studies Contracted in 2013 and 2014 Services : 2013 No.Therapeutic areaStudy Phase Development Phase Services 1Chronic parasitic diseaseon goingPartial services 2Psychologyclosed outIIIPartial services 3Cardiovascular Diseaseclosed outIIIfull services 4Pulmonary/Respiratory Diseasesclosed outIIIPartial services 5Oncologyon goingIIIPartial services 6Pulmonary/Respiratory Diseaseson goingIIIPartial services 7Pulmonary/Respiratory Diseaseson goingIIIPartial services 8Pulmonary/Respiratory Diseaseson goingIIIPartial services 9Pulmonary/Respiratory Diseaseson goingIIIPartial services

2 Industry Clinical Studies Contracted in 2013 and 2014 Services : 2014 No.Therapeutic areaStudy status Development Phase Services 1Chronic parasitic diseaseon goingPartial services 2Pulmonary/Respiratory Diseaseson goingIIIPartial services 3Pulmonary/Respiratory Diseaseson goingIIIPartial services 4Pulmonary/Respiratory Diseaseson goingIIIPartial services 5Oncologyon goingIIIPartial services 6Pulmonary/Respiratory Diseaseson goingIIIPartial services 7Obstetrics/Gynecologyon goingIIIfull services 8Surgery-Chronic Venous Diseaseon goingIIIfull services 9Ophthalmologyon goingIIIfull services 10Oncologyon goingIIIPartial services 11Respiratory Diseaseson goingOPartial services 12Respiratory Diseaseson goingIPartial services 13Oncologyon goingIIIPartial services

3 Performance 20132014 Contracted Clinical Studies New Studies 97 Cumulative Studies 913 Active Studies 913 Distribution of New Studies by Research Areas 1 Pulmonary/Respiratory Diseases ( 56%)Pulmonary/Respiratory Diseases (30%) 2 Chronic parasitic disease (11%)Oncology (23%) 3 Psychology (11%)Respiratory Diseases (15%) 4 Oncology (11%)Surgery-Chronic Venous Disease (8%) 5 Cardiovascular Disease (11%)Surgery-Chronic Venous Disease (8%) 6 Ophthalmology (8%) 7 Chronic parasitic disease (8%) Distribution of New Studies by Study Phases I 0% II 0%9% III 100%91% IV 0% Others 0%

4 โครงการวิจัยที่ใช้บริการ ACRO ตั้งแต่ปี 2013-2014 โครงการวิจัยที่ใช้บริการ ACRO แยกราย ปี

Download ppt "Industry Clinical Studies Contracted in 2013 and 2014 Services : 2013 No.Therapeutic areaStudy Phase Development Phase Services 1Chronic parasitic diseaseon."

Similar presentations

Want to SAVE a Few Million Dollars?. Give Us the OPPORTUNITY Do Just That and Well.

Want to SAVE a Few Million Dollars?. Give Us the OPPORTUNITY Do Just That and Well.
Medical Residency in Anesthesia Teaching and Practice Center in Anesthesiology: Hospital das Clinicas FMUSP Teaching and Practice Center in Anesthesiology:

Medical Residency in Anesthesia Teaching and Practice Center in Anesthesiology: Hospital das Clinicas FMUSP Teaching and Practice Center in Anesthesiology:
Algebra Recap Solve the following equations (i) 3x + 7 = 32 - 2x (ii) 3x + 1 = 5x – 13 (iii) 3(5x – 2) = 4(3x + 6) (iv) 3(2x + 1) = 2x + 11 (v) 2(x + 2)

Algebra Recap Solve the following equations (i) 3x + 7 = x (ii) 3x + 1 = 5x – 13 (iii) 3(5x – 2) = 4(3x + 6) (iv) 3(2x + 1) = 2x + 11 (v) 2(x + 2)
1 Financial Mathematics Clicker review session, Midterm 01.

1 Financial Mathematics Clicker review session, Midterm 01.
1 Financial Mathematics Clicker review session, Final.

1 Financial Mathematics Clicker review session, Final.
1 Financial Mathematics Clicker review session, Midterm 01.

1 Financial Mathematics Clicker review session, Midterm 01.
I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=
Phase Difference = 0.00. Phase Difference = 0.05.

Phase Difference = Phase Difference = 0.05.
I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=
BLOOD GAS ANALYSIS REVISION SHARON HARVEY 5/10/04.

BLOOD GAS ANALYSIS REVISION SHARON HARVEY 5/10/04.
Acute Care Exam: a Profile of Role Delineation Survey Changes (2004, 2010)

Acute Care Exam: a Profile of Role Delineation Survey Changes (2004, 2010)
Pericarditis and Myocarditis

Pericarditis and Myocarditis
S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial Efficacy and safety of ivabradine in patients with severe chronic systolic.

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial Efficacy and safety of ivabradine in patients with severe chronic systolic.
8.1.4 Can it still be factored? Factoring Completely I can factor out a common factor.

8.1.4 Can it still be factored? Factoring Completely I can factor out a common factor.
Who we are 2© 2015 INC Research, LLC Therapeutically specialized teams The complete range of Phase I to IV clinical development services Helping you develop.

Who we are 2© 2015 INC Research, LLC Therapeutically specialized teams The complete range of Phase I to IV clinical development services Helping you develop.
15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 $1 Million $500,000 $100,000 $50,000 $25,000 $10,000 $5,000 $1,000.

$1 Million $500,000 $100,000 $50,000 $25,000 $10,000 $5,000 $1,000.
基 督 再 來 （一）. 經文： 1 你們心裡不要憂愁；你們信神，也當信我。 2 在我父的家裡有許多住處；若是沒有，我就早 已告訴你們了。我去原是為你們預備地去 。 3 我 若去為你們預備了地方，就必再來接你們到我那 裡去，我在 那裡，叫你們也在那裡， ] ( 約 14 ： 1-3)

基 督 再 來 （一）. 經文： 1 你們心裡不要憂愁；你們信神，也當信我。 2 在我父的家裡有許多住處；若是沒有，我就早 已告訴你們了。我去原是為你們預備地去 。 3 我 若去為你們預備了地方，就必再來接你們到我那 裡去，我在 那裡，叫你們也在那裡， ] ( 約 14 ： 1-3)
© 2012 Cengage Learning. All Rights Reserved. May not be scanned, copied, duplicated, or posted to a publicly accessible website, in whole or in part.

© 2012 Cengage Learning. All Rights Reserved. May not be scanned, copied, duplicated, or posted to a publicly accessible website, in whole or in part.
ΟΡΓΑΝΩΣΗ ΚΑΙ ΔΙΟΙΚΗΣΗ ΕΠΙΧΕΙΡΗΣΕΩΝ 3 Ο ΜΑΘΗΜΑ. ΟΙ ΜΕΓΑΛΕΣ ΕΠΙΧΕΙΡΗΣΕΙΣ Η δημιουργία μεγάλων επιχειρήσεων είναι ένα από τα χαρακτηριστικά του 20 ου αιώνα.

ΟΡΓΑΝΩΣΗ ΚΑΙ ΔΙΟΙΚΗΣΗ ΕΠΙΧΕΙΡΗΣΕΩΝ 3 Ο ΜΑΘΗΜΑ. ΟΙ ΜΕΓΑΛΕΣ ΕΠΙΧΕΙΡΗΣΕΙΣ Η δημιουργία μεγάλων επιχειρήσεων είναι ένα από τα χαρακτηριστικά του 20 ου αιώνα.
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 

Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 

Similar presentations

Ads by Google